Works matching IS 00070920 AND DT 2021 AND VI 124 AND IP 3


Results: 21
    1
    2
    3

    The RNA polymerase I transcription inhibitor CX-5461 cooperates with topoisomerase 1 inhibition by enhancing the DNA damage response in homologous recombination-proficient high-grade serous ovarian cancer.

    Published in:
    2021
    By:
    • Yan, Shunfei;
    • Xuan, Jiachen;
    • Brajanovski, Natalie;
    • Tancock, Madeleine R. C.;
    • Madhamshettiwar, Piyush B.;
    • Simpson, Kaylene J.;
    • Ellis, Sarah;
    • Kang, Jian;
    • Cullinane, Carleen;
    • Sheppard, Karen E.;
    • Hannan, Katherine M.;
    • Hannan, Ross D.;
    • Sanij, Elaine;
    • Pearson, Richard B.;
    • Chan, Keefe T.
    Publication type:
    journal article
    4
    5

    FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial.

    Published in:
    2021
    By:
    • Heinemann, Volker;
    • von Weikersthal, Ludwig Fischer;
    • Decker, Thomas;
    • Kiani, Alexander;
    • Kaiser, Florian;
    • Al-Batran, Salah-Edin;
    • Heintges, Tobias;
    • Lerchenmüller, Christoph;
    • Kahl, Christoph;
    • Seipelt, Gernot;
    • Kullmann, Frank;
    • Moehler, Markus;
    • Scheithauer, Werner;
    • Held, Swantje;
    • Miller-Phillips, Lisa;
    • Modest, Dominik Paul;
    • Jung, Andreas;
    • Kirchner, Thomas;
    • Stintzing, Sebastian
    Publication type:
    journal article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21